Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1948 2
1949 4
1950 1
1951 2
1953 3
1954 2
1957 1
1960 1
1963 6
1969 1
1973 1
1974 1
1976 1
1977 2
1978 2
1979 1
1980 3
1981 1
1982 1
1983 1
1985 2
1986 4
1987 5
1988 6
1989 4
1990 9
1991 8
1992 10
1993 6
1994 5
1995 6
1996 12
1997 7
1998 9
1999 10
2000 16
2001 14
2002 21
2003 26
2004 19
2005 13
2006 19
2007 20
2008 24
2009 37
2010 30
2011 32
2012 35
2013 34
2014 34
2015 39
2016 32
2017 26
2018 33
2019 38
2020 27
2021 36
2022 32
2023 19

Text availability

Article attribute

Article type

Publication date

Search Results

722 results

Results by year

Filters applied: . Clear all
Page 1
Clinical applications of coenzyme Q10.
Garrido-Maraver J, Cordero MD, Oropesa-Avila M, Vega AF, de la Mata M, Pavon AD, Alcocer-Gomez E, Calero CP, Paz MV, Alanis M, de Lavera I, Cotan D, Sanchez-Alcazar JA. Garrido-Maraver J, et al. Among authors: de la mata m. Front Biosci (Landmark Ed). 2014 Jan 1;19(4):619-33. doi: 10.2741/4231. Front Biosci (Landmark Ed). 2014. PMID: 24389208 Free article. Review.
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.
de Bono JS, Mehra N, Scagliotti GV, Castro E, Dorff T, Stirling A, Stenzl A, Fleming MT, Higano CS, Saad F, Buttigliero C, van Oort IM, Laird AD, Mata M, Chen HC, Healy CG, Czibere A, Fizazi K. de Bono JS, et al. Among authors: mata m. Lancet Oncol. 2021 Sep;22(9):1250-1264. doi: 10.1016/S1470-2045(21)00376-4. Epub 2021 Aug 10. Lancet Oncol. 2021. PMID: 34388386 Clinical Trial.
Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH.
Reig M, Forner A, Ávila MA, Ayuso C, Mínguez B, Varela M, Bilbao I, Bilbao JI, Burrel M, Bustamante J, Ferrer J, Gómez MÁ, Llovet JM, De la Mata M, Matilla A, Pardo F, Pastrana MA, Rodríguez-Perálvarez M, Tabernero J, Urbano J, Vera R, Sangro B, Bruix J. Reig M, et al. Among authors: de la mata m. Med Clin (Barc). 2021 May 7;156(9):463.e1-463.e30. doi: 10.1016/j.medcli.2020.09.022. Epub 2021 Jan 16. Med Clin (Barc). 2021. PMID: 33461840 Free article. English, Spanish.
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial.
Pinyol R, Montal R, Bassaganyas L, Sia D, Takayama T, Chau GY, Mazzaferro V, Roayaie S, Lee HC, Kokudo N, Zhang Z, Torrecilla S, Moeini A, Rodriguez-Carunchio L, Gane E, Verslype C, Croitoru AE, Cillo U, de la Mata M, Lupo L, Strasser S, Park JW, Camps J, Solé M, Thung SN, Villanueva A, Pena C, Meinhardt G, Bruix J, Llovet JM. Pinyol R, et al. Among authors: de la mata m. Gut. 2019 Jun;68(6):1065-1075. doi: 10.1136/gutjnl-2018-316408. Epub 2018 Aug 14. Gut. 2019. PMID: 30108162 Free PMC article. Clinical Trial.
The authors reply.
Santos SMCD, Ramos FP, Medeiros MAT, Mata MMD, Vasconcelos FAG. Santos SMCD, et al. Among authors: mata mmd. Cad Saude Publica. 2021 Oct 29;37Suppl 1(Suppl 1):e00176521. doi: 10.1590/0102-311X00176521. eCollection 2021. Cad Saude Publica. 2021. PMID: 34730733 Free article. English, Portuguese. No abstract available.
Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma.
López-Cánovas JL, Del Rio-Moreno M, García-Fernandez H, Jiménez-Vacas JM, Moreno-Montilla MT, Sánchez-Frias ME, Amado V, L-López F, Fondevila MF, Ciria R, Gómez-Luque I, Briceño J, Nogueiras R, de la Mata M, Castaño JP, Rodriguez-Perálvarez M, Luque RM, Gahete MD. López-Cánovas JL, et al. Among authors: de la mata m. Cancer Lett. 2021 Jan 1;496:72-83. doi: 10.1016/j.canlet.2020.10.010. Epub 2020 Oct 8. Cancer Lett. 2021. PMID: 33038489
Recommendations on non-Pharmacological Treatment in Chronic Obstructive Pulmonary Disease From the Spanish COPD Guidelines (GesEPOC 2017).
Pleguezuelos E, Gimeno-Santos E, Hernández C, Mata MDC, Palacios L, Piñera P, Molina J, Chiner E, Miravitlles M. Pleguezuelos E, et al. Among authors: mata mdc. Arch Bronconeumol (Engl Ed). 2018 Nov;54(11):568-575. doi: 10.1016/j.arbres.2018.06.001. Epub 2018 Sep 18. Arch Bronconeumol (Engl Ed). 2018. PMID: 30241689 English, Spanish.
Atherosclerosis and Coenzyme Q10.
Suárez-Rivero JM, Pastor-Maldonado CJ, de la Mata M, Villanueva-Paz M, Povea-Cabello S, Álvarez-Córdoba M, Villalón-García I, Suárez-Carrillo A, Talaverón-Rey M, Munuera M, Sánchez-Alcázar JA. Suárez-Rivero JM, et al. Among authors: de la mata m. Int J Mol Sci. 2019 Oct 20;20(20):5195. doi: 10.3390/ijms20205195. Int J Mol Sci. 2019. PMID: 31635164 Free PMC article. Review.
PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing.
López-Cánovas JL, Hermán-Sánchez N, Del Rio-Moreno M, Fuentes-Fayos AC, Lara-López A, Sánchez-Frias ME, Amado V, Ciria R, Briceño J, de la Mata M, Castaño JP, Rodriguez-Perálvarez M, Luque RM, Gahete MD. López-Cánovas JL, et al. Among authors: de la mata m. Exp Mol Med. 2023 Jan;55(1):132-142. doi: 10.1038/s12276-022-00917-7. Epub 2023 Jan 6. Exp Mol Med. 2023. PMID: 36609600 Free PMC article.
722 results